STAT - Reporting from the frontiers of health and medicine

Health

First Opinion

By Justin Barad

Biotech

Health Ebola outbreak spreads to third province in eastern Congo
Biotech How Amgen plans to BiTE into CAR-T’s hype
Biotech Roche drug approval offers a glimpse at the future of cancer treatment
The Readout LOUD Listen: The serious side of spit kits, how BiTEs leave a mark, & Sarepta’s sluggish study
Health Modern science has delivered the world powerful tools to defeat Ebola. It is not enough

Exclusive analysis of biotech, pharma, and the life sciences

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Medicare could have saved billions if older generics were prescribed, study finds
Is Roche starting a price war in cancer? Maybe not
Nuclear pharmacies sue a key supplier of radiology medicines for pursuing an ‘illegal monopoly’

Special Report

First Opinion

By Dorothy Pomerantz

Exclusive

Special Report

Health Tech

Biotech

Pharmalot Medicare could have saved billions if older generics were prescribed, study finds
Health Top U.S. medical centers roll out DNA sequencing clinics for healthy (and often wealthy) clients
Politics Canadians are hopping mad about Trump’s drug importation plan. Some of them are trying to stop it
First Opinion Colorectal cancer screening: Science should trump convenience
Health FDA approves first blood sugar monitor without finger pricks